Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-03-03 @ 3:09 PM
Study NCT ID:
NCT02886702
Status:
COMPLETED
Last Update Posted:
2018-08-29
First Post:
2016-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
Sponsor:
Fougera Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-29
First Submit QC Date:
None
Study First Post Date:
2016-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-30
Results First Submit QC Date:
None
Results First Post Date:
2018-08-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-30
Last Update Post Date:
2018-08-29
Last Update Post Date Type:
ACTUAL